Skip to content
AgingResearch.News
  • HomeHome
  • SearchSearch
  • AskAsk
  • FollowingFollowing
  • SavedSaved
Join freeSign inSign inSign in
AgingResearch.NewsJoin free

COVID-19 breakthrough infection

Disease

2 papers study it

  • Human trial1
  • Animals1

Latest

Vaccine·Oct 15

Three doses of Sars-CoV-2 mRNA vaccine in older adults result in similar antibody responses but reduced cellular cytokine responses relative to younger adults

Non-randomized trial in 68 peopleInterventions
Paper
Emerging Microbes & Infections·Jan 7

Age-associated SARS-CoV-2 breakthrough infection and changes in immune response in a mouse model

Experiments in miceImmune response
Paper

Related

  • COVID-192
  • Immune response2
  • COVID-19 re-infection1
  • HAVCR21
  • IFN-gamma and IL-2 secreting T cells1
  • IFNG1
  • IL21
  • IL2RA1
  • Type I interferon signaling1
  • Adaptive antibody response1
  • COVID-19 mRNA vaccine1
  • Memory B-cells1
  • Neutralizing antibodies1
  • Soluble CD251
  • Soluble TIM-31
  • Spike-specific IgG1
AI assistantsComparePrivacyTermsContactRSSFollow on X© 2026 AgingResearch.News

    Join AgingResearch.News

    Free: every story, saved papers, follows in a daily email and 3 questions a day to Ask. 14 days of Plus to start, no card.

    Continue with email

    By continuing, you agree to our Terms and Privacy Policy.

    News

    See all
    Jonathan, the 194-year-old tortoise, shows stable epigenetic regulation of metabolism and DNA repairResearchGEN and 7 morePhysical performance declines around 35, falling 30–48% below peak by 63ResearchScienceDaily and 5 moreResearchers associate meat-derived sugar Neu5Gc with 63% higher type 2 diabetes riskResearchScienceDaily and 3 more

    Trials

    See all
    Fatigability of Lower Limb Muscle in Older Adults: Protective Effects of Strength Training Exercise in Old Men and WomenResults posted Oct 13, 2026, Marquette UniversityBenefits of Strength Training in Informal Caregivers of Patients With Alzheimer's DiseaseCompleted Oct 16, 2026, University of SalamancaFisetin for Improving Vascular Function in Older Adults: A Phase II Clinical TrialPhase 2Registered Oct 13, 2026, University of Colorado, Boulder

    Trending

    See all
    Postoperative complicationsDisease15 papers in two weeks, none in the two months beforeSleep durationExposure18 papers in two weeks, usually 2Moderate-to-vigorous physical activityIntervention12 papers in two weeks, none in the two months beforePerimenopauseDisease12 papers in two weeks, none in the two months beforeVenous thromboembolismDisease12 papers in two weeks, none in the two months beforeMetabolic disordersDisease11 papers in two weeks, none in the two months before

    Topics

    See all
    Mechanisms305Interventions627Biomarkers460Populations729AI & data128Industry & policy19SupplementsPeptidesProtocols
    • AI assistants
    • Compare
    • Privacy
    • Terms
    • Contact
    • RSS
    • Follow on X
    • © 2026 AgingResearch.News